Therapeutic innovation for multi-resistant candidemics: synergy of isavuconazole and caspofungin association
Fungal infections occurring in immunocompromised patients after immuno-chemotherapy treatment, are often difficult to eradicate and capable of even being fatal. Systemic mycoses affecting severely immunocompromised patients often manifest acutely with rapidly progressive pneumonia, fungemia, or man...
Guardado en:
Autores principales: | Andrea Duminuco, Elisa Mauro, Giuseppe A. M. Palumbo, Bruno Garibaldi, Marina Parisi, Francesco Di Raimondo, Cinzia Maugeri, Calogero Vetro |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
PAGEPress Publications
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a2c92240702f4e08a388d4bac8cdc68f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Effect of Posaconazole and Isavuconazole on the Pharmacokinetics of Erdafitinib in Beagle Dogs by UPLC-MS/MS
por: Lan-hong Ruan, et al.
Publicado: (2021) -
Oxadiazole-Containing Macrocyclic Peptides Potentiate Azole Activity against Pathogenic <italic toggle="yes">Candida</italic> Species
por: Nicole M. Revie, et al.
Publicado: (2020) - The hematology journal the official journal of the European Haematology Association /
- Hematology reviews
-
BMC blood disorders
Publicado: (2001)